Dr R Klingman, MD   Key Takeaways Governance Era:  Recent guidance from regulatory and professional bodies such as the Federal Drug Agency (FDA), European Medicines Agency (EMA) and ISMPP highlights the responsible integration of AI in medical communication and healthcare  Writing by design:  Utilizing AI as a supportive tool rather than a source—where human oversight and verification are key—reflects a “writing by design” approach  Human-in-the-loop:  Effective collaboration

This post explores why excellent data is not enough on its own and how strategic medical writing enhances the value of data in healthcare and pharmaceutical contexts.